Evidence map›Paper›PMID 35800489›Full record

ArticleJournal of family medicine and primary care2022

A rare case of misoprostol hypersensitivity.

Rituparna Das, Subrat Panda, Nalini Sharma, Prakash Deb

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rituparna DasDepartment of Obstetrics and Gynaecology, Critical Care and Pain, NEIGRIHMS, Shillong, Meghalaya, India.
Subrat PandaDepartment of Obstetrics and Gynaecology, Critical Care and Pain, NEIGRIHMS, Shillong, Meghalaya, India.
Nalini SharmaDepartment of Obstetrics and Gynaecology, Critical Care and Pain, NEIGRIHMS, Shillong, Meghalaya, India.
Prakash DebDepartment of Anaesthesia, Critical Care and Pain, NEIGRIHMS, Shillong, Meghalaya, India.
North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical abortion using mifepristone-misoprostol regimen has been considered to be a safe and effective method for pregnancy termination. Misoprostol is a frequently used well tolerated drug with mild and transient side effects. Considering the safety profile mifepristone-misoprostol regimen has also been advocated by many for home-based medical abortion. However, we report herein a rare case of hypersensitivity reaction to sublingual misoprostol administered for first trimester medical abortion, where timely diagnosis and prompt intervention prevented life-threatening airway obstruction. The possibility of such rare event should be kept in mind and included in patient counselling and information especially for those who opt for outpatient abortion care so that they can seek medical help at the earliest.

Indexed as

Adverse effectshypersensitivitymedical abortionmisoprostol

Identifiers

PMID35800489
PMCPMC9254815
OpenAlexW4284961111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.